Alert
Upgrade to PRO+
PRO+ subscribers get unlimited access to EMARKETER charts and data. Utilize our vast library of charts to validate strategic ideas and establish thought leadership via internal and external presentations.
Upgrade to PRO+
PRO+ subscribers get unlimited access to EMARKETER charts and data. Utilize our vast library of charts to validate strategic ideas and establish thought leadership via internal and external presentations.
Request successfully sent
Thank you. A member of our team will reach out shortly.
If you need immediate assistance, email us at sales@emarketer.com
March 23, 2022
Current Adoption of Connected Health Use Cases According to Life Science Executives Worldwide*, Nov 2021 (% of respondents)
Methodology
Data is from a March 2022 Capgemini report titled "Unlocking the Value in Connected Health." 523 executives, representing 166 companies from life sciences organizations in the pharmaceutical (59%) and biotechnology sectors (41%) in seven countries in North America, Europe, and Asia-Pacific were surveyed during October-November 2021. All respondents have indicated that their company is currently strategizing its approach to connected health, currently testing/developing connected health products, and/or currently have connected health products approved and in-market.Chart Title
Current Adoption of Connected Health Use Cases According to Life Science Executives Worldwide*, Nov 2021 (% of respondents)Publication Date
March 23, 2022